The company is committed to a new category development in areas like adult Immunization with products like Shingrix to make a positive impact to the lives of the patients in India
Bolsters Merck Animal Health’s position in the aqua industry with comprehensive approach to ensure fish health, welfare and sustainability in aquaculture, conservation and fisheries
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Development services for gene and cell therapies is planned to begin first in 2025
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
Receives registration of Valganciclovir powder for oral solution in Germany
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
Subscribe To Our Newsletter & Stay Updated
